JPRN-jRCT1032210360招募中未知
Construction of a highly safe leukocyte apheresis implementation system
Yanagisawa Ryu0 个研究点目标入组 15 人开始时间: 2021年10月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Cases requiring leukocyte apheresis
排除标准
- •(1) Patients for whom consent to participate in the research was not obtained
- •(2) In addition, patients who were deemed inappropriate as a subject by the principal investigator
研究者
相似试验
已完成
不适用
Validation of advanced treatment for rheumatoid arthritis (tolDC)Rheumatoid arthritisISRCTN37397692ewcastle upon Tyne Hospitals NHS Foundation Trust6
尚未招募
不适用
Safety and effectiveness of autologous leukocyte-rich platelet-rich plasma therapy (L-PRP therapy) for damage, deficit and prolonged healing in the musculoskeletal system of the human bodyintractable muscle of damaged tendon attachment and muscle tendon transitiontendonitis, humeral superior condylitis, elbow medial collateral ligament injury, knee medial collateral ligament injuryJPRN-UMIN000032134Jikei University Orthopedic5
Enrolling By Invitation
不适用
Leukapheresis for CAR or Adoptive Cell Therapy ManufacturingDiffuse Large B Cell LymphomaNon-Hodgkin's LymphomaLeukemiaAcute Lymphoblastic LeukemiaLymphomaNCT03226704National Cancer Institute (NCI)120
进行中（未招募）
1 期
Modified autologous leukocyte cells for the treatment of acute kidney injury after cardiac surgeryCTIS2023-504610-30-01M2rlab S.L.116
已完成
2 期
Rapid LeukocyAPheresis InDuction for Ulcerative Colitisulcerative colitisJPRN-UMIN000005358ower Gastroenterology, Hyogo College of Medicine40